Ovation Science Inc. (CSE: OVAT)

Market Cap	881.12K
Revenue (ttm)	101.88K
Net Income (ttm)	-636.99K
Shares Out	35.24M
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,000
Open	0.0250
Previous Close	0.0200
Day's Range	0.0250 - 0.0250
52-Week Range	0.0100 - 0.0600
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2024

About Ovation Science

Ovation Science Inc. engages in the production, sub-licensing, and sale of cannabis or hemp products in Canada and the United States. The company sublicenses product formulations through Invisicare, a patented drug delivery technology to produce topical and transdermal cannabis products under the Ovation name. It also offers cannabidiol health and wellness solutions under the Invibe MD name; skincare solutions under the ARLO CBD name; and topical and transdermal creams and lotions with CBD, THC, and combinations, as well as hemp seed oil. Ovati...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2017
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: OVAT

Financial Performance

In 2023, Ovation Science's revenue was 61,934, a decrease of -55.17% compared to the previous year's 138,154. Losses were -813,149, 2.41% more than in 2022.